Las Vegas, Nevada, Nov. 27, 2018 (GLOBE NEWSWIRE) -- International Membership Data, LLC will receive $40 Million in investment from Protect Pharmaceutical Corporation. (PRTT, Financial), an OTC publicly traded company that will accelerate the adoption of IMD’s three blockchains and launches the blockchain based Help Economy. PRTT is changing its business model and name in order to join the blockchain movement that will revolutionize all aspects of the business.
PRTT intends to change its name based on acquiring revolutionary blockchain technology and other pre-determined strategic assets from Tobit Consortium. The company has formed a wholly owned subsidiary OnliChain Holdings LLC, to facilitate these strategic acquisitions and partnerships. PRTT intends to change its corporate name to OnliChain Inc. in the first quarter of 2019.
This strategic investment was to gain exclusive rights to IMD’s blockchain methodologies, development operations, and implementation strategies. Some of their latest developed blockchains include a cryptocurrency blockchain ecosystem. CompChain a blockchain that allows you to record and pay transparent commissions to salespeople, providing an irrefutable transactional and payment record. Additionally, a third blockchain built to protect your personal data, removing the ability for others to monetize your data. These are just 3 of many blockchains being developed and optimized for the Help Economy.
Based on decades of exposure to the evolving world of data, and the misuse, and monetization of data. PRTT has changed its focus to creating an ecosystem of tools to help people and empower them to protect their data and their business from being exploited. From medical records to credit scores to home ownership the blockchain is creating new economies. People need to have an organization devoted to their protection, using the latest techniques such as blockchain. This investment is one of many being made by a consortium of companies forming the Help Economy.
When asking David Childs – CTO of IMD why he chose to align with OnliChain he stated “Technology like ours needs to be shared with the world, the quicker we can get it out there the more people who will be able to take control of their lives. OnliChain has the vision and network to get our technology out to the world.” Mr. Childs added “There is a new wave of human connection and control on its way, and these two entities saw that together they can impact the masses in a shorter amount of time. The blockchain technology will be the next era of business and personal control, creating a secure and transparent world.”
Forward-Looking Statements: This press release contains “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934. Except for historical matters contained herein, statements made in this press release are forward-looking statements. Without limiting the generality of the foregoing, words such as “may”, “will”, “to”, “plan”, “expect”, “believe”, “anticipate”, “intend”, “could”, “would”, “estimate,” or “continue”, or the negative other variations thereof or comparable terminology are intended to identify forward-looking statements.
Forward-looking statements involve known and unknown risk, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Also, forward-looking statements represent our management’s beliefs and assumptions only as of the date hereof. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in the Company's filings with the SEC including the Current Reports on Form 8-K and the Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K. Except as required by law, we assume no obligation to update these forward-looking statements publicly or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
For more information contact:
Protect Pharmaceutical Corporation 954-866-3726
